Please provide your email address to receive an email when new articles are posted on . Among targeted small-molecule drugs, deucravacitinib had the best efficacy and safety in SLE. Dose and course of ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen A. McMahon ...

Imagine your body attacking itself. That’s what happens with lupus, a chronic autoimmune disease affecting millions worldwide. Lupus Alert Day is a chance to shine a spotlight on this condition. It’s ...

Please provide your email address to receive an email when new articles are posted on . Treating patients with lupus can be likened to fighting a war, in which victory is achieved not through a single ...

Margrit Wiesendanger, MD, PhD, explores lupus symptoms, diagnosis challenges, and the importance of early detection to prevent inflammation-related damage. Wiesendanger is a clinical rheumatologist ...

BOSTON (Reuters) - Human Genome Sciences Inc said on Monday that its experimental lupus drug succeeded in a late-stage clinical trial, shocking many who had written the product off, and sending the ...

— -- Selena Gomez is finally opening up about the real reason she took some time off in 2013: The pop star was busy with treatment for lupus. In a new interview with Billboard, the actress-singer ...

NEW YORK (Reuters Health) - Older age at diagnosis and kidney inflammation are among the factors that increase the risk of blood clots in patients with systemic lupus erythematosus, or SLE, new ...